Turnstone Biologics Corp. Common Stock Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
19M
-73.66%
0M
19M
78M
18M
60M
-59M
0M
-55M
0M
-55M
79.02%
78M
0M
-56M
3M
-59M
73M
-27.64%
0M
73M
105M
18M
87M
-32M
0M
-31M
0M
-31M
-192.68%
105M
0M
-28M
4M
-32M
101M
-
0M
101M
68M
14M
55M
33M
0M
34M
0M
33M
-192.68%
68M
0M
34M
1M
33M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
0M
-100.00%
0M
0M
18M
4M
13M
-18M
0M
-17M
0M
-16M
20.36%
18M
0M
-17M
1M
-18M
0M
-100.00%
0M
0M
19M
5M
14M
-19M
0M
-17M
0M
-17M
7.23%
19M
0M
-18M
1M
-19M
0M
-100.00%
0M
0M
22M
5M
17M
-22M
0M
-22M
0M
-21M
-285.34%
22M
0M
-21M
1M
-22M
19M
80.13%
0M
19M
20M
4M
16M
0M
0M
0M
0M
0M
-100.54%
20M
0M
0M
1M
0M
10M
-
0M
10M
25M
4M
20M
-14M
0M
-14M
0M
-14M
-100.54%
25M
0M
-13M
1M
-14M
10M
-
0M
10M
26M
5M
21M
-16M
0M
-16M
0M
-16M
-100.54%
26M
0M
-15M
1M
-16M
42M
-
0M
42M
30M
4M
27M
11M
0M
12M
0M
12M
-100.54%
30M
0M
12M
1M
11M
11M
-
0M
11M
23M
5M
19M
-13M
0M
-13M
0M
-13M
-100.54%
23M
0M
-12M
0M
-13M